![](/img/cover-not-exists.png)
396 Ixekizumab treatment shows a neutral impact on the glucose and lipid profile of patients with moderate-to-severe psoriasis: Results from UNCOVER-1,-2, and -3
Wu, J.J., Egeberg, A., Solomon, J.A., Osuntokun, O., Goldblum, O., Moriarty, S., Zhao, F., Korman, N., Vincent, M.Volume:
137
Language:
english
Journal:
Journal of Investigative Dermatology
DOI:
10.1016/j.jid.2017.07.591
Date:
October, 2017
File:
PDF, 430 KB
english, 2017